JGRO JPMorgan Active Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 10.88% |
| AAPL | 8.73% |
| GOOG | 7.17% |
| MSFT | 4.97% |
| AVGO | 3.98% |
| TSLA | 3.65% |
| META | 3.54% |
| AMZN | 3.35% |
| MA | 2.08% |
| LLY | 1.96% |
ETF Analysis
Fund Overview
JPMorgan Active Growth ETF (JGRO) currently reports 119 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is NVDA (10.88%), AAPL (8.73%), GOOG (7.17%), with NVDA as the largest single weight at 10.88%. Together, the top three holdings account for 26.78%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 40.28%, WACC is 10.47%, and the economic spread is 29.81%. On balance, the spread between returns and capital costs is exceptional, meaning reinvested capital is creating significant incremental value at the portfolio level. Supporting metrics show ROE at 48.45% and ROA at 14.89%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
Assessed on a multiple basis, trailing P/E of 32.28, forward P/E of 24.91, PEG of 2.10. Forward P/E comes in somewhat below trailing — a gap that is supportive of the valuation case without implying a sharp near-term earnings inflection. Growth-adjusted, the multiple is in an acceptable range — the portfolio is neither pricing in perfection nor offering a meaningful valuation discount. The portfolio carries an aggregate current ratio of 1.96, consistent with adequate near-term liquidity management. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 57.29%, operating margin at 27.23%, and free cash flow margin at 23.55%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.
Growth & Forward Outlook
The forward view combines two signals: the estimated 12-month price change of 24.39%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 25.05% suggesting the portfolio's businesses are collectively capturing meaningful market share or pricing power. The projected 12-month EPS growth rate of 29.6% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyPutting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.